High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients

Journal of Medical Virology

Volumn 86, Issue 11, 2014, Pages 1953-1961

  dos Santos, Claudia Januário ^a   Stangherlin, Lucas Matheus ^a   Figueiredo, Eberval Gadelha ^b   Corrêa, Clemar ^b   Teixeira, Manoel Jacobsen ^b   da Silva, Maria Cristina Carlan ^a  

^a UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Detection; Glioblastoma multiforme; Human cytomegalovirus

Indexed keywords

CELL DNA; VIRUS DNA;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER PATIENT; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENOTYPE; GLIOBLASTOMA; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; NESTED POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; VIRUS GENOME; VIRUS LOAD; BLOOD; BRAIN; COMPLICATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ISOLATION AND PURIFICATION; PREVALENCE; VIROLOGY;

BLOOD; BRAIN; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GLIOBLASTOMA; HUMANS; POLYMERASE CHAIN REACTION; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84908150909     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23820     Document Type: Article

References (63)

1. Affronti ML, Heery CR, Herndon JE II, Rich JN, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Bigner DD, Friedman HS. 2009. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. Cancer 115:3501-3511.
2. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Fruh K. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci 93:10990-10995.
3. Carraro E, Granato CF. 2003. Single human cytomegalovirus gB genotype shed in multiple sites at the time of diagnosis in renal transplant recipients. J Med Virol 70:240-243.
4. Chou SW, Dennison KM. 1991. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 163:1229-1234.
5. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ. 2002. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347-3350.
6. Cobbs CS, Soroceanu L, Denham S, Zhang W, Kraus MH. 2008. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res 68:724-730.
7. Correia-Silva JF, Resende RG, Arao TC, Abreu MH, Teixeira MM, Bittencourt H, Silva TA, Gomez RS. 2011. HCMV gB genotype and its association with cytokine levels in hematopoietic stem cell transplantation. Oral Dis 17:530-537.
8. Cunha AA, Marin LJ, Aquino VH, Figueiredo LT. 2002. Diagnosis of cytomegalovirus infections by qualitative and quantitative PCR in HIV infected patients. Rev Inst Med Trop 44:127-132.
9. Dix AR, Brooks WH, Roszman TL, Morford LA. 1999. Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 100:216-232.
10. Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L, Cobbs CS; HCMV and Gliomas Symposium. 2012. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro-Oncology 14:246-255.
11. El-Shinawi M, Mohamed HT, El-Ghonaimy EA, Tantawy M, Younis A, Schneider RJ, Mohamed MM. 2013. Human cytomegalovirusinfection enhances NF-kappaB/p65 signaling in inflammatory breast cancer patients. PLoS ONE 8:e55755.
12. Fonseca RF, Kawamura MT, Oliveira JA, Teixeira A, Alves G, Carvalho Mda G. 2012. The prevalence of human cytomegalovirusDNA in gliomas of Brazilian patients. Mem Inst Oswaldo Cruz 107:953-954.
13. Fritschy JM, Brandner S, Aguzzi A, Koedood M, Luscher B, Mitchell PJ. 1996. Brain cell type specificity and gliosis-induced activation of the human cytomegalovirusimmediate-early promoter in transgenic mice. J Neurosci 16:2275-2282.
14. Gomez GG, Hickey MJ, Tritz R, Kruse CA. 2008. Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: Downregulation of multiple proapoptotic factors. Gene Ther Mol Biol 12:101-110.
15. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144:646-674.
16. Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS. 2002. Specific localisation of human cytomegalovirusnucleic acids and proteins in human colorectal cancer. Lancet 360:1557-1563.
17. Holland EC. 2000. Glioblastoma multiforme: The terminator. Proc Natl Acad Sci 97:6242-6244.
18. Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta RF. 2008. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320:797-799.
19. Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL. 1996. Human cytomegalovirusUS3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci 93:11327-11333.
20. Kalejta RF, Bechtel JT, Shenk T. 2003. Human cytomegaloviruspp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol 23:1885-1895.
21. Khan Z, Yaiw KC, Wilhelmi V, Lam H, Rahbar A, Stragliotto G, Soderberg-Naucler C. 2013. Human cytomegalovirus immediateearly proteins promote degradation of connexin 43 and disrupt gap junction communication: Implications for a role in gliomagenesis. Carcinogenesis doi: 10.1093/carcin/bgt292
22. Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, Weiss LM. 2005. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18:838-843.
23. Lehrer S, Labombardi V, Green S, Pessin-Minsley MS, Germano IM, Rosenzweig KE. 2011. No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res 31:959-960.
24. Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C. 2011. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neuro-Oncol 103:231-238.
25. Machold RP, Wiertz EJ, Jones TR, Ploegh HL. 1997. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med 185:363-366.
26. Matlaf LA, Harkins LE, Bezrookove V, Cobbs CS, Soroceanu L. 2013. Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS ONE 8:e68176.
27. Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, PleskoffO, Michel D, van Dongen GA, Smit MJ. 2006. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci 103:13068-13073.
28. Melnick M, Deluca KA, Sedghizadeh PP, Jaskoll T. 2013. Cytomegalovirus-induced salivary gland pathology: AREG, FGF8, TNFalpha, and IL-6 signal dysregulation and neoplasia. Exp Mol Pathol 94:386-397.
29. Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH. 2008. Sensitive detection of human cytomegalovirusin tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-oncology 10:10-18.
30. Mitchell DP, Savaryn JP, Moorman NJ, Shenk T, Terhune SS. 2009. Human cytomegalovirusUL28 and UL29 open reading frames encode a spliced mRNA and stimulate accumulation of immediate-early RNAs. J Virol 83:10187-10197.
31. Mockarsi EJ, Shenk T, Pass RP. 2006. Cytomegalovirus. In: Knipe DM, Howley PM, editors. Fields virology, 5th edition. Philadelphia, PA: Lippincott-Raven.
32. Moore PS, Chang Y. 2010. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 10:878-889.
33. Ogura T, Tanaka J, Kamiya S, Sato H, Ogura H, Hatano M. 1986. Human cytomegaloviruspersistent infection in a human central nervous system cell line: Production of a variant virus with different growth characteristics. J Gen Virol 67:2605-2616.
34. Ohgaki H. 2009. Epidemiology of brain tumors. Methods Mol Biol 472:323-342.
35. Poland SD, Costello P, Dekaban GA, Rice GP. 1990. Cytomegalovirus in the brain: In vitro infection of human brain-derived cells. J Infect Dis 162:1252-1262.
36. Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR. 2006. Lack of association of herpesviruses with brain tumors. J Neurovirol 12:90-99.
37. Preiser W, Brauninger S, Schwerdtfeger R, Ayliffe U, Garson JA, Brink NS, Franck S, Doerr HW, Rabenau HF. 2001. Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants. J Clin Virol 20:59-70.
38. Price RL, Bingmer K, Harkins L, Iwenofu OH, Kwon CH, Cook C, Pelloski C, Chiocca EA. 2012. Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/-mice. Cancer Res 72:5669-5674.
39. Rahbar A, Orrego A, Peredo I, Dzabic M, Wolmer-Solberg N, Straat K, Stragliotto G, Soderberg-Naucler C. 2013. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol 57:36-42.
40. Rahbar A, Stragliotto G, Orrego A, Peredo I, Taher C, Willems J, Soderberg-Naucler C. 2012. Low levels of human cytomegalovirus infection in glioblastoma multiforme associates with patient survival; a case-control study. Herpesviridae 3:3.
41. Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF. 2012. Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. J Virol 86:854-864.
42. Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF. 2011. Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog 7:e1001344.
43. Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Tremoulet M, Delisle MB, Brousset P. 2005. Detection of human cytomegalovirusgenome and gene products in central nervous system tumours. Br J Cancer 92:747-750.
44. Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS. 2003. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170:998-1002.
45. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R. 2008. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116:79-86.
46. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R. 1996. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 174:184-187.
47. Siew VK, Duh CY, Wang SK. 2009. Human cytomegalovirus UL76 induces chromosome aberrations. J Biomed Sci 16:107.
48. Sissons JG, Carmichael AJ. 2002. Clinical aspects and management of cytomegalovirus infection. J Infect 44:78-783.
49. Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, Fraile-Ramos A, Lira SA, Soderberg-Naucler C, Smit MJ. 2010. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 3:ra58.
50. Soderberg-Naucler C. 2008. HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 41:218-223.
51. Soderberg-Naucler C, Rahbar A, Stragliotto G. 2013. Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 369:985-986.
52. Soroceanu L, Akhavan A, Cobbs CS. 2008. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455:391-395.
53. Soroceanu L, Matlaf L, Bezrookove V, Harkins L, Martinez R, Greene M, Soteropoulos P, Cobbs CS. 2011. Human cytomegalovirusUS28 found in glioblastoma promotes an invasive and angiogenic phenotype. Cancer Res 71:6643-6653.
54. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
55. Straat K, Liu C, Rahbar A, Zhu Q, Liu L, Wolmer-Solberg N, Lou F, Liu Z, Shen J, Jia J, Kyo S, Bjorkholm M, Sjoberg J, Soderberg-Naucler C, Xu D. 2009. Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst 101:488-497.
56. Trincado DE, Scott GM, White PA, Hunt C, Rasmussen L, Rawlinson WD. 2000. Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 61:481-487.
57. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-779.
58. Wolmer-Solberg N, Baryawno N, Rahbar A, Fuchs D, Odeberg J, Taher C, Wilhelmi V, Milosevic J, Mohammad AA, Martinsson T, Sveinbjörnsson B, Johnsen JI, Kogner P, Söderberg-Nauclér C. 2013. Frequent detection of human cytomegalovirus in neuroblastoma: A novel therapeutic target? Int J Cancer 133: 2351-2361. doi: 10.1002/ijc.28265
59. Yamamoto AY, Mussi-Pinhata MM, de Deus Wagatsuma VM, Marin LJ, Duarte G, Figueiredo LT. 2007. Human cytomegalovirusglycoprotein B genotypes in Brazilian mothers and their congenitally infected infants. J Med Virol 79:1164-1168.
60. Zafiropoulos A, Tsentelierou E, Billiri K, Spandidos DA. 2003. Human herpes viruses in non-melanoma skin cancers. Cancer Lett 198:77-81.
61. Zekri AR, Mohamed WS, Samra MA, Sherif GM, El-Shehaby AM, El-Sayed MH. 2004. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Transpl Immunol 13:305-311.
62. Zheng SS ZL, Qian J, Cai T, Fan J, Ma WH. 2002. Cytomegalovirus glycoprotein B sequence variation in Chinese liver transplant recipients. Hepatobiliary Pancreat Dis Int 1:26-29.
63. Zhu H, Shen Y, Shenk T. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 69:7960-7970.